Alcon

News

Alcon eyes $770m takeover of ophthalmology specialist Aerie

Swiss eyecare firm Alcon has made a move to boost its position in ophthalmological medicines with a $15.25 per share offer to buy Aerie Pharmaceuticals in a transaction that values the U

News

Novartis, Alcon settle US bribery charges with £347 million ...

Novartis and eyecare spinout Alcon have agreed to settle bribery charges brought by the US federal authorities, focused on activities in Greece and other countries, for $347 mi

News

Novartis completes spin-out of Alcon eye unit

Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products.

News

Novartis confirms Alcon eye care unit spin off next month

Novartis has finalised plans for the long-awaited spin-off of its Alcon eye care business, announcing that the new company will list on April 9.

News

Alcon to build digital platform to improve cataract surgery

Novartis’ ophthalmology division Alcon has announced plans to build a digital platform to streamline, simplify and improve cataract surgery for surgeons and patients.

News